Venom evolution
![]() Venom researcher, Bryan Fry, collects a reef cuttlefish (Sepia latimanus) in the Coral Sea. Photo: Alexia Maddox |
I am working on a general theory of how venom evolves by applying all the theories I developed on reptile venom evolution, to other orders. I am currently concentrating on the molecular evolution of venom proteins in cephalopods (cuttlefish, nautiluses, octopuses and squids) from tropical and temperate waters. As with snakes and lizards, there are many more venomous cephalopod species than appreciated.
During the recent Collaborative East Antarctic Marine Census I was astounded at the biodiversity of the Antarctic waters. The tropics are always portrayed in documentaries as marine hotspots. They are, of course, much more accessible and amenable for research than Antarctic waters. But the sheer quantity and diversity of life in the Southern Ocean rivals anything I have seen on my expeditions to the Great Barrier Reef, Coral Sea, Asia, the Caribbean, or other locations in-between. Two venomous lineages – octopuses and anemones – were very well represented, both in total numbers and species diversity.
![]() This octopus, Megaleledone setebos, collected for venom research during CEAMARC, is endemic to Antarctica. Photo: Robin Beaman |
The second step will be to obtain a snapshot of every protein being produced at the time the venom glands were removed. I have already achieved this with octopuses, cuttlefish, centipedes, fish, snakes and even the venom glands of the iconic Komodo Dragon. My studies of octopus and cuttlefish venom glands show that they have toxic proteins in common, resulting from early 'recruitment' events into the chemical arsenal of their common ancestor. However, during the subsequent evolution of the animals themselves, they have recruited new proteins into the chemical arsenal that are unique to each lineage. This shows that while cephalopods share a common venomous ancestor, the venom system continues to diversify.
The third step in the process will identify the spectrum or range of proteins in the venom and their relative quantities. The glands of each specimen will be analysed separately to reveal their unique molecular fingerprints, thus revealing any regional variation within and between species.
These results will guide bioactivity testing to determine the effects of the crude venom and purified individual toxins on living cells. The activity of the crude venom is greater than the sum of the individual components, due to the synergistic action that often occurs between different molecules.
Of particular interest will be the gene sequences and actions of enzymes from cold water cephalopod species (from Antarctica and Norway), with the same types of enzymes from temperate and tropical species. Temperature is a major variable in the action of enzymes and most enzymes have a narrow 'sweet spot' of optimal activity. As the same enzyme classes are shared between tropical and Antarctic species, significant biochemical changes must exist between them in order for activity to occur at the radically different temperatures (32ºC versus –2ºC). The fundamental changes responsible for the activity at different temperatures will be elucidated by comparing differences in the sequence of amino acids (protein building blocks) and then making chimeric versions of the proteins in the laboratory to determine which amino acids confer the temperature-dependent activities.
In our studies of temperate and tropical species so far, we have discovered new small proteins with very intriguing activities, which are potentially useful in drug design and development. We will be searching for new small proteins in the venoms of the specimens we have collected on this expedition.
The trip to Antarctica was not only a professional bonanza but also as close to a religious experience as I will ever get. I hope one day to return to the mecca of the frozen South.
*In addition to the award of berths by the Australian Antarctic Division, this research is funded by the Australian Research Council, Australian Academy of Sciences (J.G. Russell Award), the CASS Foundation and the Australian & Pacific Science Foundation.
BRYAN GRIEG FRY
Group Leader, Venomics Research Laboratory,
Department of Biochemistry & Molecular Biology,
Bio21 Institute, University of Melbourne
![]() Dr Bryan Fry with an olive sea snake (Aipysurus laevis) Photo: David Wachenfeld |
Back to Antarctic Magazine 14: 2008 index
Next article Supporting scientists at sea


